Genomictree Statistics
Total Valuation
Genomictree has a market cap or net worth of KRW 312.78 billion. The enterprise value is 221.33 billion.
Market Cap | 312.78B |
Enterprise Value | 221.33B |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Genomictree has 24.00 million shares outstanding. The number of shares has increased by 7.01% in one year.
Current Share Class | 24.00M |
Shares Outstanding | 24.00M |
Shares Change (YoY) | +7.01% |
Shares Change (QoQ) | +0.29% |
Owned by Insiders (%) | 16.02% |
Owned by Institutions (%) | 1.02% |
Float | 20.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 130.65 |
PB Ratio | 2.57 |
P/TBV Ratio | 2.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -21.07 |
EV / Sales | 92.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -14.50 |
Financial Position
The company has a current ratio of 20.48, with a Debt / Equity ratio of 0.02.
Current Ratio | 20.48 |
Quick Ratio | 20.26 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | -0.14 |
Interest Coverage | -49.74 |
Financial Efficiency
Return on equity (ROE) is -8.65% and return on invested capital (ROIC) is -7.59%.
Return on Equity (ROE) | -8.65% |
Return on Assets (ROA) | -7.30% |
Return on Invested Capital (ROIC) | -7.59% |
Return on Capital Employed (ROCE) | -12.30% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.02 |
Inventory Turnover | 7.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.44% in the last 52 weeks. The beta is 0.09, so Genomictree's price volatility has been lower than the market average.
Beta (5Y) | 0.09 |
52-Week Price Change | -36.44% |
50-Day Moving Average | 14,665.60 |
200-Day Moving Average | 16,999.25 |
Relative Strength Index (RSI) | 37.98 |
Average Volume (20 Days) | 88,727 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genomictree had revenue of KRW 2.39 billion and -10.50 billion in losses. Loss per share was -432.68.
Revenue | 2.39B |
Gross Profit | -628.10M |
Operating Income | -15.16B |
Pretax Income | -10.63B |
Net Income | -10.50B |
EBITDA | -13.95B |
EBIT | -15.16B |
Loss Per Share | -432.68 |
Balance Sheet
The company has 93.99 billion in cash and 2.15 billion in debt, giving a net cash position of 91.84 billion or 3,826.06 per share.
Cash & Cash Equivalents | 93.99B |
Total Debt | 2.15B |
Net Cash | 91.84B |
Net Cash Per Share | 3,826.06 |
Equity (Book Value) | 121.59B |
Book Value Per Share | 5,037.37 |
Working Capital | 90.82B |
Cash Flow
In the last 12 months, operating cash flow was -12.95 billion and capital expenditures -2.31 billion, giving a free cash flow of -15.26 billion.
Operating Cash Flow | -12.95B |
Capital Expenditures | -2.31B |
Free Cash Flow | -15.26B |
FCF Per Share | -635.85 |
Margins
Gross Margin | -26.24% |
Operating Margin | -633.39% |
Pretax Margin | -444.02% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Genomictree does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.01% |
Shareholder Yield | n/a |
Earnings Yield | -3.36% |
FCF Yield | -4.88% |
Stock Splits
The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.
Last Split Date | Sep 14, 2018 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Genomictree has an Altman Z-Score of 43.59.
Altman Z-Score | 43.59 |
Piotroski F-Score | n/a |